Cargando…
Pituitary surgery for small prolactinomas as an alternative to treatment with dopamine agonists
Despite the fact that consensus guidelines recommend long-term dopamine agonist (DA) therapy as a first-line approach to the treatment of small prolactinoma, some patients continue to prefer a primary surgical approach. Concerns over potential adverse effects of long-term medical therapy and/or the...
Autores principales: | Babey, Muriel, Sahli, Rahel, Vajtai, Istvan, Andres, Robert H., Seiler, Rolf W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3146980/ https://www.ncbi.nlm.nih.gov/pubmed/21170594 http://dx.doi.org/10.1007/s11102-010-0283-y |
Ejemplares similares
-
Manifestation of a sellar hemangioblastoma due to pituitary apoplexy: a case report
por: Schär, Ralph T, et al.
Publicado: (2011) -
Folliculo-stellate cells of "true dendritic" type are involved in the inflammatory microenvironment of tumor immunosurveillance of pituitary adenomas
por: Vajtai, Istvan, et al.
Publicado: (2007) -
Long-term Outcome of Microscopic Transsphenoidal Surgery for Prolactinomas as an Alternative to Dopamine Agonists
por: Park, Kawngwoo, et al.
Publicado: (2021) -
Dopamine agonist resistant prolactinomas: any alternative medical treatment?
por: Souteiro, P., et al.
Publicado: (2019) -
The Mechanism and Pathways of Dopamine and Dopamine Agonists in Prolactinomas
por: Liu, Xiaoshuang, et al.
Publicado: (2019)